Nature Reviews - Cardiology

MAY 2, 2024

Nature Reviews Cardiology, Published online: 03 May 2024; doi:10.1038/s41569-024-01031-z In the AEGIS-II trial, infusion of apolipoprotein A-I to increase cholesterol efflux capacity did not improve outcomes in patients with acute myocardial infarction.

Myocardial Infarction 64

Myocardial Infarction Cholesterol Outcomes 64

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

ST-elevation myocardial infarction (STEMI) is a critical cardiovascular emergency characterized by acute coronary artery occlusion and subsequent myocardial injury. However, despite successful revascularization, microvascular obstruction (MVO) remains a major challenge, contributing to adverse clinical outcomes.

Thrombolysis 52

Thrombolysis STEMI Myocardial Infarction Article 52

Frontiers in Cardiovascular Medicine

APRIL 1, 2025

IntroductionDepression is a significant comorbidity linked to poor subjective and objective health outcomes in cardiac patients. The paucity of data necessitates further research to elucidate the pathophysiological connection between depression and cardiac diseases in the presence of N-terminal pro-brain natriuretic peptide (NT-proBNP).

Biomarkers 69

Biomarkers Coronary Artery Disease Article Myocardial Infarction 69

Frontiers in Cardiovascular Medicine

MARCH 27, 2025

Observational studies and randomised controlled trials (RCTs) have yielded conflicting results regarding the outcomes of multiple arterial grafts (MAG) vs. single arterial grafts (SAG) in coronary artery bypass graft (CABG) surgery. We conducted a comprehensive search across multiple databases for RCTs that directly compared MAG and SAG.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Myocardial Infarction Strokes Stroke 52

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2023

Objectives There is no consensus regarding the optimal choice between single long stent (SLS) and overlapped double short stents (DSS) in patients with acute myocardial infarction (AMI). Therefore, we aimed to compare treatment outcomes among patients with AMI treated with these two different stenting methods. years, and 75.0%

Stents 64

Stents Stent Myocardial Infarction Outcomes 64

Open Heart

MARCH 28, 2025

Background High-sensitivity cardiac troponin tests have enhanced early myocardial infarction diagnosis, yet many patients still land in the observe zone (OZ). The prevalence of non-ST-segment elevation myocardial infarction (NSTEMI) within the OZ was 7.2%. Results Of the 4605 patients, 948 were triaged to the OZ (20.6%).

Myocardial Infarction 52

Myocardial Infarction Outcomes 52

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. The odds of adverse outcomes such as mortality (aOR 3.90, 95% CI: 3.48–4.36), Mortality (43.2%

COVID-19 52

COVID-19 Myocardial Infarction Hospital ICU 52

American College of Cardiology

DECEMBER 2, 2024

Current guidelines regarding beta-blocker use after myocardial infarction (MI) recommend against continuation to improve outcomes after 1 year, in the absence of reduced left ventricular ejection fraction (LVEF; <50%) or other primary indications for therapy.

Myocardial Infarction 49

Myocardial Infarction Outcomes Article 49

Journal of the American Heart Association

FEBRUARY 28, 2024

We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self‐reported cardiovascular outcomes (coronary heart disease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old.

Myocardial Infarction 76

Myocardial Infarction Outcomes Heart Disease Stroke 76

Frontiers in Cardiovascular Medicine

MARCH 10, 2024

Background Hyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). There are conflicting sources regarding the relationship between hyperglycemia and outcomes in STEMI patients. 3.45) and 4.47 (95% CI: 2.54–7.87),

Myocardial Infarction 59

Myocardial Infarction Cardiogenic Shock Article STEMI 59

Med Page Today

NOVEMBER 17, 2024

(MedPage Today) -- CHICAGO -- A mineralocorticoid receptor antagonist (MRA) was unable to further improve 3-year outcomes of acute myocardial infarction (MI) in the modern era, based on the CLEAR OASIS 9 trial. Among heart attack survivors without.

Myocardial Infarction 104

Myocardial Infarction Heart Attack Heart attacks Outcomes 104

Frontiers in Cardiovascular Medicine

JANUARY 3, 2024

Background Microcirculatory dysfunction is an independent risk factor for a poor prognosis after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). However, its effects on microcirculation in patients with AMI after primary PCI remain unknown.

Myocardial Infarction 59

Myocardial Infarction Outcomes Cardiac Function Thrombolysis 59

Journal of the American Heart Association

MARCH 27, 2025

BackgroundRecent evidence highlights an increasing incidence of myocardial infarction in young women. The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models.

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

Cardio-cerebral infarction (CCI) is a rare clinical syndrome characterized by the simultaneous or sequential occurrence of acute myocardial infarction (AMI) and acute ischemic stroke (AIS). Consequently, clinicians often rely on single-disease guidelines for AMI or AIS, or personal experience, when managing CCI cases.

Myocardial Infarction 52

Myocardial Infarction Article Research Patient Care 52

Open Heart

JANUARY 11, 2024

This study aimed to investigate the association between the use of GTN before percutaneous coronary intervention (PCI) for ACS and clinical outcomes. Conclusions GTN use preceding PCI for ACS is associated with lower blood pressure and adverse clinical outcomes in elderly patients. –143.5) mm Hg vs 134.0 –157.0)

Blood Pressure 98

Blood Pressure Outcomes Myocardial Infarction Heart Failure 98

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

BackgroundThe pharmacoinvasive (PhI) strategy is the standard-of-care for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (pPCI) is unfeasible. Multivariable logistic regression models were used to assess the association between lysis-PCI timing and outcomes.

Myocardial Infarction 52

Myocardial Infarction Outcomes STEMI Hospital 52

Journal of the American Heart Association

DECEMBER 24, 2024

The primary outcome was atherothrombotic major adverse cardiovascular events as a composite outcome of cardiovascular mortality, nonfatal stroke, and nonfatal myocardial infarction. Patients were propensity matched in a 1:1 ratio using a caliper distance of 0.2 without replacement.

Diabetes 75

Diabetes Myocardial Infarction Outcomes Strokes 75

American College of Cardiology

NOVEMBER 7, 2024

Does the development of cardiovascular (CV) events, specifically myocardial infarction (MI) or heart failure (HF), in breast cancer survivors influence their oncologic outcomes?

Cancer 61

Cancer Myocardial Infarction Outcomes Heart Failure 61

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

Individual outcomes, including all-cause mortality, myocardial infarction, and revascularization, also showed no significant differences between the two groups. Before propensity score (PS) matching, the POCE incidence was 3.1% in the BB group vs. 3.4% in the non-BB group [hazard ratio (HR) 0.86, 95% confidence interval (CI) 0.68–1.09,

Myocardial Infarction 45

Myocardial Infarction Kidney Disease Outcomes Research 45

Open Heart

JANUARY 19, 2025

Aim This study aimed to systematically review and analyse the existing evidence on outcomes of emergency transcatheter aortic valve implantation (eTAVI) and emergency balloon aortic valvuloplasty (eBAV) in CS patients. Despite advancements in emergency interventions, the optimal treatment approach remains uncertain.

Cardiogenic Shock 52

Cardiogenic Shock Aortic Stenosis Aortic valve 52

Journal of the American Heart Association

MARCH 26, 2025

The primary outcome was inhospital allcause mortality. Multivariable logistic regression models were used to estimate BMIstratified associations between SMuRFless status and outcomes.ResultsThe study included 44 538 patients with firstpresentation acute myocardial infarction, of whom 4454 were SMuRFless.

Myocardial Infarction 40

Myocardial Infarction Risk Factors BMI Obesity 40

Journal of the American Heart Association

APRIL 10, 2025

BackgroundPatients 80 years old were underrepresented or excluded from landmark trials demonstrating the superiority of primary percutaneous coronary intervention (PCI) in STsegmentelevation myocardial infarction. The primary outcome was overall survival.

Myocardial Infarction 45

Myocardial Infarction Outcomes 45

Heart BMJ

JULY 10, 2024

Background Despite restoration of epicardial blood flow in acute ST-elevation myocardial infarction (STEMI), inadequate microcirculatory perfusion is common and portends a poor prognosis. Intracoronary (IC) thrombolytic therapy can reduce microvascular thrombotic burden; however, contemporary studies have produced conflicting outcomes.

Myocardial Infarction 52

Myocardial Infarction Thrombolysis STEMI Outcomes 52

Med Page Today

APRIL 8, 2024

(MedPage Today) -- ATLANTA -- Chelation to remove lead and other heavy metals didn't improve outcomes for type 2 diabetes patients after myocardial infarction (MI), the TACT2 trial showed. Cumulative incidence of time to first event (MI, stroke.

Heart Attack 95

Heart Attack Heart attacks Myocardial Infarction Diabetes 95

Frontiers in Cardiovascular Medicine

DECEMBER 9, 2024

Therefore, this meta-analysis aimed to estimate association between TMAO levels and the prognosis of patients with myocardial infarction (MI).MethodsWe Outcomes included MACE, all-cause mortality, recurrent MI, rehospitalization caused by heart failure, stroke, revascularization, SYNTAX score, and multivessel disease.

Myocardial Infarction 52

Myocardial Infarction Biomarkers Heart Failure Strokes 52

Med Page Today

APRIL 10, 2024

(MedPage Today) -- ATLANTA -- Fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease did not result in better outcomes compared.

Coronary Artery Disease 64

Coronary Artery Disease Myocardial Infarction Outcomes STEMI 64

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

We present the case of an 80-year-old woman with a small aortic annulus who underwent TAVR using a self-expanding transcatheter heart valve Acurate Neo2 after an non-ST-segment elevation myocardial infarction (NSTEMI) presentation.

Aortic valve 52

Aortic valve Aortic TAVR Myocardial Infarction 52

Cardiovascular Diabetology

AUGUST 6, 2024

Data on major cardiovascular events (MACE; mortality, myocardial infarction, stroke, heart failure) through December 2021 were obtained from national registries. Results Among all patients (n = 38,671), 31% had stable CAD, and 69% suffered an acute myocardial infarction. vs. 6.8%), myocardial infarction (7.7%

Coronary Artery Disease 98

Coronary Artery Disease Diabetes Myocardial Infarction Heart Failure 98

Open Heart

JANUARY 29, 2024

Objectives This study aimed to perform a meta-analysis of the short-term impact of ischaemic postconditioning (IPoC) on myocardial injury in ST elevation myocardial infarction (STEMI) using surrogate cardiac biomarkers. Few studies used troponin as an outcome, thus, a subanalysis of troponin dynamics was not performed.

Myocardial Infarction 52

Myocardial Infarction STEMI Article Biomarkers 52

Cardiovascular Diabetology

DECEMBER 5, 2023

Stress hyperglycemia ratio (SHR), associated with adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), has several definitions. This study aims to assess the prognostic value o.

Myocardial Infarction 45

Myocardial Infarction STEMI Outcomes Research 45

Heart BMJ

DECEMBER 20, 2023

Background Patients from lower socioeconomic status areas have poorer outcomes following acute myocardial infarction (AMI); however, how ethnicity modifies such socioeconomic disparities is unclear.

Myocardial Infarction 40

Myocardial Infarction Outcomes Hospital Education 40

American College of Cardiology

NOVEMBER 7, 2024

What is the impact of complete revascularization versus culprit-only revascularization on outcomes in older patients with ST-segment elevation myocardial infarction (STEMI) and non–ST-segment elevation myocardial infarction (NSTEMI)?

STEMI 67

STEMI Myocardial Infarction Outcomes Article 67

NEJM Journal Watch - Cardiology

SEPTEMBER 4, 2024

Invasive and conservative strategies had similar outcomes in a randomized trial involving patients age 75 years or older with non–ST-segment elevation myocardial infarction.

Myocardial Infarction 74

Myocardial Infarction Outcomes 74

The American Journal of Cardiology

MAY 21, 2024

Publication date: Available online 20 May 2024 Source: The American Journal of Cardiology Author(s): Marsioleda Kemberi, Eduardo Urgesi, Ji ngYong Ng, Kush Patel, Mohammed Y Khanji, Wael I Awad

Myocardial Infarction 52

Myocardial Infarction Outcomes 52

Circulation: Cardiovascular Quality & Outcomes

JANUARY 19, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) differ with respect to demographics, comorbidities, treatments, and clinical outcomes. T1MI and 53.5% T2MI; mean age, 79±10.3 years; 47% female).

Myocardial Infarction 40

Myocardial Infarction COVID-19 Medicare Hospital 40

Heart BMJ

MARCH 12, 2024

Learning objectives To review the epidemiology, clinical presentation and diagnosis of mechanical complications of acute myocardial infarction including ventricular septal defect, free wall rupture and papillary muscle rupture. To discuss the existing data on outcomes of medical therapy, surgery and percutaneous intervention.

Myocardial Infarction 40

Myocardial Infarction VSD Outcomes 40

Cardiovascular Diabetology

MAY 6, 2024

Given the increasing attention to glycemic variability (GV) and its potential implications for cardiovascular outcomes. This study aimed to explore the impact of acute GV on short-term outcomes in Chinese pati.

Myocardial Infarction 52

Myocardial Infarction Outcomes Research 52